Castle Biosciences CSTL
NASDAQ CSTL
$35.36 +0.37 (+1.06%)
As of: Sep 22, 2026 · 10:13 AM EDT

Castle Biosciences (CSTL) Non-Current Assets (2018 - 2026)

Castle Biosciences' (CSTL) quarterly Non-Current Assets came in at $220.1 million in Q2 2026, up 12.25% year-over-year from $196.1 million in Q2 2025, and up 0.54% quarter-over-quarter from $218.9 million in Q1 2026.

Analysis

Castle Biosciences (CSTL) Non-Current Assets (2018 - 2026) Analysis & Trends

Castle Biosciences has disclosed Non-Current Assets across 9 years of filings, most recently posting $220.1 million for Q2 2026.

  • In Q2 2026, Non-Current Assets rose 12.25% year-over-year to $220.1 million; the TTM figure through Jun 2026 stood at $861.7 million (up 25.01% YoY), while the FY2025 annual figure was $217.5 million, up 27.11% from the prior year.
  • Non-Current Assets came in at $220.1 million for Q2 2026 at Castle Biosciences, up from $218.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $220.1 million in Q2 2026 to a low of $108.0 million in Q1 2022.
  • Average Non-Current Assets over 5 years is $171.2 million, with a median of $160.6 million recorded in 2022.
  • Year-over-year, Non-Current Assets surged 912.79% in 2022 and fell 6.39% in 2025.
  • Over 5 years, Non-Current Assets stood at $155.0 million in 2022, then climbed by 1.72% to $157.7 million in 2023, then gained by 8.48% to $171.1 million in 2024, then gained by 27.11% to $217.5 million in 2025, then rose by 1.2% to $220.1 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $220.1 million in Q2 2026, $218.9 million in Q1 2026, and $217.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 998.55 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 14.10 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 14.72 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 547.66 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 14.60 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 171.79 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 2.66 Bn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 78.32 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 220.12 Mn
10 Castle Biosciences 1.08 Bn 811.36 Mn 79.85 Mn 220.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 220.08 Mn
Mar 31, 2026 218.90 Mn
Dec 31, 2025 217.46 Mn
Sep 30, 2025 205.22 Mn
Jun 30, 2025 196.06 Mn
Mar 31, 2025 152.33 Mn
Dec 31, 2024 171.08 Mn
Sep 30, 2024 169.79 Mn
Jun 30, 2024 166.91 Mn
Mar 31, 2024 162.73 Mn
Dec 31, 2023 157.71 Mn
Sep 30, 2023 156.40 Mn
Jun 30, 2023 156.35 Mn
Mar 31, 2023 155.79 Mn
Dec 31, 2022 155.04 Mn
Sep 30, 2022 158.40 Mn
Jun 30, 2022 153.47 Mn
Mar 31, 2022 107.98 Mn
Dec 31, 2021 108.83 Mn
Sep 30, 2021 44.11 Mn
API Access

Castle Biosciences Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=CSTL&period=max&api_key=YOUR_API_KEY